Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials.

Introduction: Incorporation of AKT inhibitors into adjuvant therapy for advanced or metastatic breast cancer has improved clinical outcomes. However, the safety of AKT inhibitors should be better evaluated, given the possibility of prolonging survival and impacting patient quality of life. Our aim w...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Clinical Pharmacology Vol. 80; no. 9; pp. 1373 - 1386
Autores principales:	de Moraes, Francisco Cezar Aquino, Sano, Vitor Kendi Tsuchiya, Pereira, Caroline R. M., de Laia, Estella Aparecida, Stecca, Carlos, Magalhães, Maria Cristina Figueroa, Burbano, Rommel Mario Rodríguez
Formato:	meta analysis research systematic review tables/charts Journal Article
Publicado:	Springer Nature Sep2024
Acceso en línea:	Ver este registro en EBSCOhost